The British premium skincare brand will join forces with L’Oréal’s LUXE Division after signing an agreement that will see the founder, management and its private equity partners, Inflexion, remain involved in the running of the business.
The collaboration signals a new chapter of growth for the B Corp™ certified clinical skincare brand, which currently operates a multi-channel model across Europe, Australia and with a growing presence in the US.
“This is an exciting day for our brand”, said Simon Coble, CEO of Medik8. “With the support of Inflexion, we’ve shown Medik8 to be a formidable force, powered by high-quality, clinically proven results without compromise. We now enter our next phase of growth, with L’Oréal’s support, enabling us to further strengthen our innovation capabilities and reach even more customers worldwide”.
Founded by scientist Elliot Isaacs in 2009, Medik8 is available via Professional Clinics, Pharmacies, its DTC website, Etailers, and Retailers, including Space NK, Sephora UK, and Harrods. Best known for its iconic Crystal Retinal serum and trademark CSA Philosophy®, Vitamin C and Sunscreen by Day, Vitamin A by night, the brand offers high-quality active skincare products that are formulated and manufactured in-house, in their UK Innovation Centre, outside London.
Elliot Isaacs, Medik8 Founder, commented: “Medik8 was born to prove that skincare can deliver results without compromise – rooted in science, obsessed with customer experience, and driven by sustainability. I’m delighted that Medik8 has now found its long-term home at L’Oréal – a partner that fundamentally embraces our vision and gives us the platform to deliver it on a truly global scale.”
Cyril Chapuy, President of L’Oréal LUXE, added: “We are delighted to welcome Medik8 to the L’Oréal family. As a premium skincare range, with high levels of proven efficacy at an accessible price point, Medik8 perfectly complements our existing skincare portfolio. We share a strong belief in Medik8’s global potential and are excited to embark on this journey together to build a powerful and impactful brand presence worldwide.”
“Medik8 has always been such a unique and differentiated business, with a brilliant product-led culture”, added Tom Pemberton, Partner and Head of Consumer at Inflexion. “I’m extremely proud of what we have achieved so far, and I am delighted to work alongside L’Oréal in this next chapter.”
The transaction is expected to be completed in the next few months after regulatory approvals and other customary conditions.
